ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients.

Liu D, Hao Q, Li J, Li Q, Wang K, Geng Q, Wu Y, Vadgama JV, Wu Y. ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients. Cancer Commun (Lond). 2022 07; 42(7):663-667.

View in: PubMed

subject areas

Breast Neoplasms
Cell Line, Tumor
Disease-Free Survival
Female
Humans
Interferons
Receptors, Estrogen

authors with profiles

Jaydutt V Vadgama, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support